Inovio, AstraZeneca terminate cancer vaccine partnership
November 02, 2021 at 11:36 AM EDT
Plymouth Meeting-based Inovio had the potential to earn up to $700 million through the original collaboration entered into six years ago.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|